Top Buy
Wertpapier | Buy | Sell | Buy (1M) | Sell (1M) | Kurs | Kursziel | Potential |
---|---|---|---|---|---|---|---|
Eli Lilly Corp. | 50 | 0 | 5 | 0 | 723,70 € | 766,92 € | 5,97 % |
Biogen Inc. | 45 | 2 | 5 | 1 | 203,10 € | 294,01 € | 44,76 % |
Vertex Pharmaceuticals Inc. | 43 | 2 | 7 | 0 | 381,00 € | 386,76 € | 1,51 % |
Regeneron Pharmaceuticals Inc. | 34 | 1 | 6 | 1 | 895,40 € | 957,22 € | 6,90 % |
Johnson & Johnson | 32 | 1 | 3 | 0 | 138,50 € | 196,74 € | 42,05 % |
Pfizer Inc. | 31 | 4 | 3 | 1 | 26,07 € | 41,10 € | 57,69 % |
Merck & Co. Inc. | 28 | 1 | 2 | 0 | 119,80 € | 124,92 € | 4,28 % |
Amgen Inc. | 24 | 0 | 5 | 0 | 278,95 € | 296,16 € | 6,17 % |
Zoetis Inc. A | 22 | 1 | 4 | 0 | 159,00 € | 198,11 € | 24,60 % |
AbbVie Inc. | 21 | 0 | 4 | 0 | 150,72 € | 174,43 € | 15,73 % |
Abbott Laboratories | 16 | 0 | 2 | 0 | 98,78 € | 116,81 € | 18,25 % |
Gilead Sciences Inc | 12 | 1 | 5 | 0 | 61,36 € | 86,77 € | 41,41 % |
Incyte Corp. | 12 | 2 | 3 | 1 | 50,38 € | 78,42 € | 55,66 % |